inflammation

The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis.

Related Articles The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis. Pulm Pharmacol Ther. 2016 Nov 2;: Authors: Baldissera L, Squebola-Cola DM, Calixto MC, Lima-Barbosa AP, Rennó AL, Anhê GF, Condino-Neto A, De…

Assessing the Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma and Allergic Rhinitis

Conditions:   Asthma, Allergic;   Rhinitis,Allergic;   AllergyInterventions:   Drug: Azelastine-Fluticasone Nasal;   Drug: PlacebosSponsor:   University of DundeeNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers

Conditions:   Lung Inflammation;   HIV SeropositivityInterventions:   Other: ECIGS;   Behavioral: mobile contingency management (mCM);   Other: Usual brandSponsors:   Duke University;   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting – verified May 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last…